Archive · 1 Dec 2025
India's penicillin production faces Chinese price undercutting
India wants to make its own important medicines, like penicillin, to be self-reliant.
A big company, Aurobindo Pharma, built a large factory to make penicillin.
But then, other countries, especially China, started selling penicillin much cheaper.
This makes it hard for India to compete.
Some people think India should set a minimum price for imported penicillin to help its own factories.
Others think Indian companies should find ways to make their products cheaper.
This is important because it could help India become a leader in making important medicines again.
India aims to be self-reliant in antibiotic production, particularly Penicillin-G, through the PLI Scheme.
Aurobindo Pharma invested ₹2,500 crore in a Pen-G facility with an annual capacity of 15,000 metric tonnes.
Chinese exporters reduced Pen-G export prices by 40%, threatening India's domestic production efforts.
Analysts suggest implementing a Minimum Import Price (MIP) for Pen-G to protect domestic production.
Indian companies are exploring cost optimization and expanding into downstream antibiotics to compete sustainably.
- Who
- India's pharmaceutical industry, particularly Aurobindo Pharma, and Chinese exporters
- What
- Chinese exporters are aggressively undercutting prices of Penicillin-G, threatening India's self-reliance efforts in antibiotic production
- When
- The price undercutting began soon after the commissioning of Aurobindo's Pen-G facility, with significant drops observed from March 2024 to August 2025
- Where
- The issue is primarily affecting India's domestic pharmaceutical production, with implications for global markets
- Why
- Chinese exporters are reducing prices to discourage new domestic capacity creation in India, posing a challenge to India's Atmanirbhar (self-reliance) goals
- India's generic drug market share in the US
- over 40%
- FDA-approved sites in India
- over 700
- India's dependency on imports for Penicillin-G
- almost 100%
- Aurobindo Pharma's investment in Pen-G facility
- ₹2,500 crore
- Annual capacity of Aurobindo's Pen-G facility
- 15,000 metric tonnes
- Price drop of Pen-G from China
- 40% from Rs 2500/kg to Rs 1500/kg
- Time for fermentation-based operations to achieve optimal efficiency
- 2–3 years